Eden Research plc (FRA:9T7)
Germany · Delayed Price · Currency is EUR 0.0390
-0.0005 (-1.27%)
At close: Jan 30, 2026
Eden Research Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3.62 | 4.3 | 3.19 | 1.83 | 1.23 | 1.37 | |
Revenue Growth (YoY) | -8.14% | 34.79% | 74.70% | 48.72% | -10.26% | -25.01% |
Cost of Revenue | 1.74 | 2.43 | 1.43 | 1 | 0.67 | 0.74 |
Gross Profit | 1.87 | 1.87 | 1.77 | 0.83 | 0.56 | 0.63 |
Selling, General & Admin | 3.66 | 3.51 | 3 | 2.75 | 2.69 | 2.2 |
Amortization of Goodwill & Intangibles | 0.5 | 0.36 | 0.42 | 0.5 | 0.43 | 0.55 |
Other Operating Expenses | -0.03 | -0.02 | -0.02 | - | - | - |
Operating Expenses | 4.38 | 4.06 | 3.63 | 3.4 | 3.77 | 2.88 |
Operating Income | -2.51 | -2.19 | -1.87 | -2.57 | -3.21 | -2.24 |
Interest Expense | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
Interest & Investment Income | 0.08 | 0.11 | 0.03 | 0 | 0 | 0.01 |
Earnings From Equity Investments | -0.01 | 0 | -0.03 | -0.03 | -0.06 | -0.03 |
Currency Exchange Gain (Loss) | -0.09 | -0.1 | -0.07 | 0.05 | -0.1 | 0.04 |
Other Non Operating Income (Expenses) | -0 | -0 | -0 | - | - | - |
EBT Excluding Unusual Items | -2.54 | -2.18 | -1.95 | -2.57 | -3.4 | -2.26 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.3 |
Asset Writedown | - | - | -4.97 | - | - | - |
Other Unusual Items | - | - | - | - | - | 0.01 |
Pretax Income | -2.54 | -2.18 | -6.92 | -2.57 | -3.4 | -2.55 |
Income Tax Expense | -0.19 | -0.27 | -0.43 | -0.32 | -0.62 | -0.29 |
Earnings From Continuing Operations | -2.34 | -1.91 | -6.49 | -2.24 | -2.78 | -2.26 |
Minority Interest in Earnings | -0.01 | 0.01 | -0 | 0.01 | -0.01 | -0.01 |
Net Income | -2.35 | -1.91 | -6.49 | -2.24 | -2.79 | -2.27 |
Net Income to Common | -2.35 | -1.91 | -6.49 | -2.24 | -2.79 | -2.27 |
Shares Outstanding (Basic) | 533 | 533 | 421 | 381 | 380 | 345 |
Shares Outstanding (Diluted) | 533 | 533 | 421 | 381 | 380 | 345 |
Shares Change (YoY) | 7.28% | 26.71% | 10.61% | 0.06% | 10.36% | 65.49% |
EPS (Basic) | -0.00 | -0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
Free Cash Flow | -0.23 | -1.06 | -1.8 | -0.71 | -1.69 | -1.22 |
Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | 51.81% | 43.51% | 55.31% | 45.43% | 45.68% | 46.20% |
Operating Margin | -69.34% | -50.81% | -58.48% | -140.49% | -261.14% | -163.86% |
Profit Margin | -65.01% | -44.31% | -203.45% | -122.44% | -227.01% | -165.84% |
Free Cash Flow Margin | -6.29% | -24.57% | -56.32% | -39.09% | -137.38% | -89.25% |
EBITDA | -2.34 | -2.02 | -1.63 | -2.29 | -2.93 | -1.99 |
EBITDA Margin | -64.60% | -47.02% | -51.09% | -125.38% | -238.59% | -145.58% |
D&A For EBITDA | 0.17 | 0.16 | 0.24 | 0.28 | 0.28 | 0.25 |
EBIT | -2.51 | -2.19 | -1.87 | -2.57 | -3.21 | -2.24 |
EBIT Margin | -69.34% | -50.81% | -58.48% | -140.49% | -261.14% | -163.86% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.